Product Information

BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB is a generic product labeled by Larken Laboratories, Inc., priced at $0.5304 per EA under NDC 68047072101. Its NADAC has been published 549 times since May 18, 2016.

FDA first approved this application on Dec 4, 2015. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB

butalbital and acetaminophen
$0.5304per EA
DEA Schedule CIII

Strength

325; 50 mg/1; mg/1

NDC

68047072101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACETAMINOPHEN; BUTALBITAL

Approval Type

Generic (ANDA)

FDA Application

ANDA203484

FDA Approved

12/4/2015

TE Code

AA

On Market Since

12/4/2015

Pharmacological Classes

Barbiturate
Barbiturates

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has been published 549 times since May 18, 2016, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5304 per EA
All-time high$1.2418 (Jun 15, 2016)
All-time low$0.4121 (Nov 20, 2024)
52-week high$0.7122
52-week low$0.5304
Median price$0.9283
Average price$0.9014
Largest weekly change+47.5% (Sep 21, 2022)
Weeks tracked549
Tracking sinceMay 18, 2016

Price History

1W

-3.8%

1M

-7.1%

3M

-10.0%

6M

-12.2%

1Y

-6.3%

3Y

-46.5%

5Y

-30.2%

All

-57.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, manufactured by Larken Laboratories, Inc., is $0.5304 per EA (NDC 68047072101), effective Nov 18, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has declined 57.3%. It has been tracked across 549 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?

Since May 18, 2016, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has ranged from a low of $0.4121 (Nov 20, 2024) to a high of $1.2418 (Jun 15, 2016), with a median of $0.9283 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?

BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB (NDC 68047072101) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.